Image

    Novel Cycle Changes in Scalp Hair Are Caused by Etretinate Therapy

    March 1995 in “ British Journal of Dermatology
    J. Berth‐Jones, P.E. Hutchinson
    Studysummary This study reported that etretinate treatment leads to increased hair shedding due to a sustained decrease in anagen duration, with an arrest at the onset of anagen and a follicular anchorage defect in telogen contributing to alopecia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Telogen Effluvium: New Concepts and Review Archives of Dermatology · 1993
    2. A Study of Etretinate-Induced Alopecia British Journal of Dermatology · 1990

    Related research 4

    1. Scalp Hair Loss Is Not Random Across Follicular Units: A New Insight Into Human Hair Aging International Journal of Cosmetic Science · 2023
    2. A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan Indian Journal of Dermatology · 2019
    3. Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus Case Reports in Dermatology · 2017
    4. Hair Loss in Children: Common and Uncommon Causes; Clinical and Epidemiological Study in Jordan International Journal of Trichology · 2013